Financial Year |
March 31 2023 |
Monetary Funds |
481,535,678.27 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
349,186,027.30 |
Accounts Receivable |
388,397,019.44 |
Advances to Suppliers |
219,756,588.05 |
Other Receivables |
193,318,294.37 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,086,037,553.28 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
170,474,654.76 |
Total Current Assets |
3,903,798,679.04 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
3,994,757,387.19 |
Under-construction Projects |
414,008,748.01 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
695,216,661.72 |
R&D expenses |
697,345.14 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
21,512,987.27 |
Deferred Income Tax Assets |
35,948,311.82 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
5,188,578,776.69 |
Total Assets |
9,092,377,455.73 |
Short-Term Loans |
2,211,650,014.07 |
Trading Financial liabilities |
5,085,503.01 |
Notes Payable |
676,610,000.00 |
Accounts Payable |
624,068,657.62 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
41,075,486.36 |
Taxes Payable |
47,766,495.78 |
Interest Payable |
-- |
Dividend Payable |
1,440,000.00 |
Other payables |
767,078,046.54 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
498,996,366.64 |
Other Current Liabilities |
331,203,952.72 |
Sub-Total of Current Liabilities |
5,432,257,498.16 |
Long-term Loans |
962,589,250.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
284,452,475.75 |
Special Payable |
-- |
Estimatied Liabilities |
49,946,248.13 |
Deferred Income Tax Liabilities |
147,176.84 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,487,748,428.51 |
Total Liabilities |
6,920,005,926.67 |
Paid-In Capital(Or Share Stock) |
914,635,329.00 |
Capital Surplus |
2,073,333,652.58 |
Surplus Reserve |
95,095,815.42 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-2,534,569,194.00 |
Minority Stockholder's Interest |
111,745,615.08 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,060,625,913.98 |
Owner's Equity(Stockholder's Equity) |
2,172,371,529.06 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
9,092,377,455.73 |